Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Current Assets (2022 - 2025)

Historic Current Assets for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $3.0 million.

  • Addex Therapeutics' Current Assets fell 3710.33% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 3710.33%. This contributed to the annual value of $4.0 million for FY2024, which is 1462.4% down from last year.
  • According to the latest figures from Q3 2025, Addex Therapeutics' Current Assets is $3.0 million, which was down 3710.33% from $3.2 million recorded in Q2 2025.
  • Addex Therapeutics' 5-year Current Assets high stood at $18.6 million for Q1 2022, and its period low was $3.0 million during Q3 2025.
  • Moreover, its 4-year median value for Current Assets was $5.2 million (2024), whereas its average is $7.1 million.
  • As far as peak fluctuations go, Addex Therapeutics' Current Assets tumbled by 5977.06% in 2023, and later crashed by 584.61% in 2025.
  • Quarter analysis of 4 years shows Addex Therapeutics' Current Assets stood at $8.1 million in 2022, then tumbled by 41.26% to $4.8 million in 2023, then decreased by 15.32% to $4.0 million in 2024, then dropped by 26.88% to $3.0 million in 2025.
  • Its Current Assets stands at $3.0 million for Q3 2025, versus $3.2 million for Q2 2025 and $3.6 million for Q1 2025.